Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glomerulonephritis, IGA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT04564339
What this trial is testing

Study of Ravulizumab in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN)

Who this might be right for
Lupus NephritisImmunoglobulin A Nephropathy
Alexion Pharmaceuticals, Inc. 123
Large-scale testing (Phase 3)Looking for participantsNCT07390123
What this trial is testing

Phase Ⅲ Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients With Primary IgAN

Who this might be right for
IgA Nephropathy (IgAN)
Haisco Pharmaceutical Group Co., Ltd. 370
Post-approval studies (Phase 4)UnknownNCT02231125
What this trial is testing

Efficacy and Safety of Abelmoschus Manihot for IgA Nephropathy

Who this might be right for
IgA Nephropathy
Chen Xiangmei 1,600
Not applicableStudy completedNCT03488368
What this trial is testing

Longterm Renal Oucomes of STOP-IgAN Trial Participants

Who this might be right for
IgA Nephropathy
RWTH Aachen University 148
Large-scale testing (Phase 3)Active Not RecruitingNCT05797610
What this trial is testing

Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression

Who this might be right for
Primary IgA Nephropathy
Hoffmann-La Roche 459
Large-scale testing (Phase 3)Not Yet RecruitingNCT06580288
What this trial is testing

Effect of Finerenone in IgA Nephropathy

Who this might be right for
IgA Nephropathy
Zhejiang University 120
Testing effectiveness (Phase 2)Ended earlyNCT05847920
What this trial is testing

Efficacy and Safety of SHR-2010 Injection in the Treatment of Primary IgA Nephropathy

Who this might be right for
Primary IgA Nephropathy
Guangdong Hengrui Pharmaceutical Co., Ltd 53
Not applicableUnknownNCT01815190
What this trial is testing

IgA-positive Versus IgA-negative Immune Complex Vasculitis

Who this might be right for
Cutaneous Vasculitis
University Hospital Muenster 300
Large-scale testing (Phase 3)Active Not RecruitingNCT05248646
What this trial is testing

Trial of Sibeprenlimab in the Treatment of A Nephropathy (IgAN)

Who this might be right for
Immunoglobulin A Nephropathy
Otsuka Pharmaceutical Development & Commercialization, Inc. 530
Post-approval studies (Phase 4)UnknownNCT03218852
What this trial is testing

Extended Follow-up of Treatment of Prednisone Plus Cyclophosphamide in Patients With Advanced-stage IgA Nephropathy

Who this might be right for
IgA Nephropathy
Guangdong Provincial People's Hospital 133
Large-scale testing (Phase 3)Looking for participantsNCT06858319
What this trial is testing

Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.

Who this might be right for
Kidney DiseasesKidney Diseases, ChronicUrological Diseases+5 more
Novartis Pharmaceuticals 220
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06674577
What this trial is testing

A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Atacicept

Who this might be right for
IgA Nephropathy (IgAN)Renal and Urinary DisordersBerger Disease
Vera Therapeutics, Inc. 750
Very early researchLooking for participantsNCT07586267
What this trial is testing

CD19/BCMA UCAR-T for B Cell-Related Autoimmune Disease

Who this might be right for
Autoimmune DiseasesSystemic Lupus Erthematosus (SLE)Multi-Drug Resistant Nephrotic Syndrome+3 more
The Children's Hospital of Zhejiang University School of Medicine 15
Large-scale testing (Phase 3)Looking for participantsNCT06819826
What this trial is testing

SC0062 Capsule for the Treatment of IgA Nephropathy with Proteinuria

Who this might be right for
IgA Nephropathy (IgAN)
Biocity Biopharmaceutics Co., Ltd. 360
Testing effectiveness (Phase 2)Study completedNCT05834738
What this trial is testing

Randomized, Double-blind, Placebo-controlled, Crossover Study of Atrasentan in Subjects With IgA Nephropathy

Who this might be right for
IgA NephropathyImmunoglobulin A Nephropathy
Novartis Pharmaceuticals 54
Large-scale testing (Phase 3)Active Not RecruitingNCT06564142
What this trial is testing

Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)

Who this might be right for
Immunoglobulin A Nephropathy
Alpine Immune Sciences Inc, A Subsidiary of Vertex 605
Early research (Phase 1)Study completedNCT05398510
What this trial is testing

Evaluate the Safety, Tolerability and Pharmacokinetics Pharmacodynamics of SHR-2010 by Intravenously/Subcutaneously in Healthy Subject

Who this might be right for
IgA Nephropathy
Guangdong Hengrui Pharmaceutical Co., Ltd 61
Large-scale testing (Phase 3)Active Not RecruitingNCT03418779
What this trial is testing

Treatment Effects of Chinese Medicine (Yi-Qi-Qing-Jie Herbal Compound) Combined With Immunosuppression Therapies in IgA Nephropathy Patients With High-risk of ESRD

Who this might be right for
IgA Nephropathy at High Risk of Developing ESRD
Guang'anmen Hospital of China Academy of Chinese Medical Sciences 60
Testing effectiveness (Phase 2)Looking for participantsNCT05775042
What this trial is testing

Clinical Study of CM338 in the Treatment of Immunoglobulin A Nephropathy

Who this might be right for
IgA Nephropathy
Keymed Biosciences Co.Ltd 70
Early research (Phase 1)Not Yet RecruitingNCT07445906
What this trial is testing

RG002C0106 Injection in Adult Participants With Normal Renal Function and Mild-to-Moderate Renal Impairment

Who this might be right for
Renal ImpairmentsIgA Nephropathy (IgAN)
Rigerna Therapeutics Co., Ltd.; Rigerna Therapeutics (Beijing) Co., Ltd. 24
Next Page